Emergent Biosolutions, Inc. EBS
$6.23
+6.13%
at last close
Financials (TTM)
- Revenue
- $770.20 million
- Net Income
- $-176,800,000
- Net Margin
- -22.96%
- Return on Equity
- -51.79%
- Debt-to-Equity
- 1.73
- P/E Ratio
- —
- Price / Book
- 0.94
- Price / Sales
- 0.41
Over the trailing twelve months, Emergent Biosolutions, Inc. generated revenue of $770.20 million and net income of $-176,800,000, a net margin of -22.96%.
At the last closing price of $6.23, EBS trades at 0.41 times sales, with a market capitalization of $319.43 million.
Key Stats
- Last Close
- $6.23
- Market Cap
- $319.43 million
- 52-Week Range
- $4.36 – $14.06
- Average Volume
- 1.42 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.